Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design
James E. Crowe
Cell Host & Microbe (2017) Vol. 22, Iss. 2, pp. 193-206
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

High frequency of shared clonotypes in human B cell receptor repertoires
Cinque Soto, Robin G. Bombardi, Andre Branchizio, et al.
Nature (2019) Vol. 566, Iss. 7744, pp. 398-402
Open Access | Times Cited: 300
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M. Gunn, Wen‐Han Yu, Marcus M. Karim, et al.
Cell Host & Microbe (2018) Vol. 24, Iss. 2, pp. 221-233.e5
Open Access | Times Cited: 215
Antibody responses to viral infections: a structural perspective across three different enveloped viruses
Charles D. Murin, Ian A. Wilson, Andrew B. Ward
Nature Microbiology (2019) Vol. 4, Iss. 5, pp. 734-747
Open Access | Times Cited: 193
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
Chunyan Wang, Rien van Haperen, Francisco J. Gutierrez-Alvarez, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 173
The 1918 influenza pandemic: 100 years of questions answered and unanswered
Jeffery K. Taubenberger, John C. Kash, David M. Morens
Science Translational Medicine (2019) Vol. 11, Iss. 502
Open Access | Times Cited: 169
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization
Rui Kong, Hongying Duan, Zizhang Sheng, et al.
Cell (2019) Vol. 178, Iss. 3, pp. 567-584.e19
Open Access | Times Cited: 126
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization
Rui Kong, Hongying Duan, Zizhang Sheng, et al.
Cell (2019) Vol. 178, Iss. 3, pp. 567
Closed Access | Times Cited: 101
The 1918 Influenza Pandemic and Its Legacy
Jeffery K. Taubenberger, David M. Morens
Cold Spring Harbor Perspectives in Medicine (2019) Vol. 10, Iss. 10, pp. a038695-a038695
Open Access | Times Cited: 100
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Pavlo Gilchuk, Charles D. Murin, Jacob C. Milligan, et al.
Immunity (2020) Vol. 52, Iss. 2, pp. 388-403.e12
Open Access | Times Cited: 83
Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens
Ron Yefet, Nadav Friedel, Hadas Tamir, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105957-105957
Open Access | Times Cited: 31
Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient
Peihua Niu, Senyan Zhang, Pan-Pan Zhou, et al.
The Journal of Infectious Diseases (2018) Vol. 218, Iss. 8, pp. 1249-1260
Open Access | Times Cited: 72
CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential
Andrea J. Sant, Anthony DiPiazza, Jennifer L. Nayak, et al.
Immunological Reviews (2018) Vol. 284, Iss. 1, pp. 91-105
Open Access | Times Cited: 69
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
Thach H. Chu, Andrew R. Crowley, Iara M. Backes, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 2, pp. e1008083-e1008083
Open Access | Times Cited: 68
Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective
Anders Madsen, Ya-Nan Dai, Meagan McMahon, et al.
Immunity (2020) Vol. 53, Iss. 4, pp. 852-863.e7
Open Access | Times Cited: 60
Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics
Pavlo Gilchuk, Robin G. Bombardi, Jesse H. Erasmus, et al.
Nature Biomedical Engineering (2020) Vol. 4, Iss. 11, pp. 1030-1043
Open Access | Times Cited: 55
Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
Beatriz Escudero-Pérez, Philip Lawrence, Javier Castillo‐Olivares
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era
Simone Pecetta, Oretta Finco, Anja Seubert
Seminars in Immunology (2020) Vol. 50, pp. 101427-101427
Open Access | Times Cited: 44
Ebola virus antibody decay–stimulation in a high proportion of survivors
Charlene Adaken, J. T. Scott, Raman Sharma, et al.
Nature (2021) Vol. 590, Iss. 7846, pp. 468-472
Open Access | Times Cited: 36
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
Michael P. Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Cell Reports (2021) Vol. 36, Iss. 9, pp. 109628-109628
Open Access | Times Cited: 36
Influenza Virus Infection Enhances Antibody-Mediated NK Cell Functions via Type I Interferon-Dependent Pathways
Sinthujan Jegaskanda, Hillary A. Vanderven, Hyon‐Xhi Tan, et al.
Journal of Virology (2018) Vol. 93, Iss. 5
Open Access | Times Cited: 39
Inducing broad-based immunity against viruses with pandemic potential
Alessandro Sette, Erica Ollmann Saphire
Immunity (2022) Vol. 55, Iss. 5, pp. 738-748
Open Access | Times Cited: 21
Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody
Wen-Fan Shen, Jedhan Ucat Galula, Jyung‐Hurng Liu, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 35
Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
Vincent Dussupt, Kayvon Modjarrad, Shelly J. Krebs
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 24
Protective antibodies against human parainfluenza virus type 3 infection
Jim Boonyaratanakornkit, Suruchi Singh, Connor Weidle, et al.
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 23
High-Throughput B Cell Epitope Determination by Next-Generation Sequencing
Lauren Walker, Andrea R. Shiakolas, Rohit Venkat, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top